POSTER SESSION IV Tuesday, February 14, 2006   —  1:00 - 4:30 PM Exhibit Level GENITOURINARY PATHOLOGY 66 COX-2 Expression In Prostate Needle Core Biopsies- Comparison Of Prostatis And Prostate Cancer (629) R Gandour-Edwards, A Tsodikov, D Hwang, RW deVere White - University of California Davis, Sacramento, CA 67 DicarbonylL-xylulose Reductase (DCXR): a New Potential Marker for Prostate Adenocarcinoma Identified by LCM-microSAGE (608) JH Cho-Vega, S Tsavachidis, K-A Do, P Troncoso, LJ Medeiros, R Lopez, TJ McDonnell - The Methodist Hospital, MD Anderson Cancer Center, Houston, TX 68 An Inverse Relationship Between E-cadherin And COX-2 Expression Correlates With Aggressive Histologic Features In Prostate Cancer (722) DS Rao, D Gui, RW Reiter, JW Said - UCLA, Los Angeles, CA 69 Annexin II Immunoreactivity In Prostate Tissue: A Tissue Microarray (TMA) Study (754) J Stewart, H Cole, N Fleshner, J Sweet - Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada 70 Expression of CDX2 in Adenocarcinoma of the Prostate (PCa) (647) M Herawi, G Kristiansen, AM De Marzo, JI Epstein - Johns Hopkins Medical Institutions, Baltimore, MD 71 Minichromosome Maintenance Protein 6 Expression In The Prostate: A Tissue Microarray Analysis (746) RA Simon, PA Bourne, PA diSant'Agnese, J Huang, JL Yao - University of Rochester Medical Center, Rochester, NY 72 B-RAF and K-RAS Mutations in Prostatic Adenocarcinoma (607) N-Y Cho, BH Kim, Y-M Cho, KC Moon, GH Kang - Seoul National University, Asan Medical Center, Seoul, Republic of Korea 73 Proteomic Analysis Of Protein Expression In Prostate Cancer (673) H Lexander, C Palmberg, G Auer, M Hellström, B Franzén, H Jörnvall, L Egevad - Karolinska Institute, Karolinska Hospital, Stockholm, Sweden; Astra-Zeneca R&D, Södertilje, Sweden 74 Spondin-2 (DD-P108) Expression In Carcinoma Of The Prostate: A Study Of 121 Patients (749) ML Smith, KR Shroyer, KC Torkko, I Simon, RA Fan, NW Kim, MS Lucia - University of Colorado at Denver & Health Sciences Center, Denver, CO; diaDexus Inc, San Francisco, CA 75 Stathmin is Over Expressed in Metastatic Prostate Cancer: Implications in Prostate Cancer Progression (689) R Mehra, L Poisson, S Varambally, S Tomlins, L Kunju, D Ghosh, A Chinnaiyan, RB Shah - The University of Michigan, Ann Arbor, MI 76 E-Cadherin Protein Expression of Prostate Adenocarcinoma Independently Predicts Salvage Radiotherapy Outcomes (723) M Ray, R Mehra, H Sandler, S Daignault, RB Shah - University of Michigan, Ann Arbor, MI 77 Immunohistochemical Analysis of the mTOR Pathway in Prostatic Cancer. p4EBP1 as a Potential Marker of High Risk HGPIN (655) C Iglesias, I de Torres, F Rojo, M Cuatrecasas, L Najera, J Jimenez, J Morote, S Ramon y Cajal - Vall d'Hebron University Hospital, Barcelona, Spain 78 Tumor Suppressor Gene PTEN in Prostate Cancer: A Potential Therapeutic Target (683) C Magi-Galluzzi, M Skacel, L Sercia, J Garcia, A Reuther, E Klein, R Dreicer, M Zhou - Cleveland Clinic Foundation 79 Expression of Caveolin Proteins in Prostatic Adenocarcinoma (615) AM De Marzo, J Luo, M Nakayama, C Bennett, SW Fine - Johns Hopkins University, Baltimore, MD 80 Mirror Image Tissue Banking Of Radical Prostatectomy Specimens Enables Isolation Of Epithelial Plasma Membranes For Proteomics While Preserving Pathologic Quality Of Retrieved Tissues (747) K Sircar, L Gaboury, E Scarlatta, M Mecteau, A Aprikian, S Tanguay, N Fahmy, J Lanoix - McGill University Health Center, Centre Hospitalier Universitaire de Montreal, Caprion Pharmaceuticals, Montreal, QC, Canada 81 Functional Characterization of the Metastasis-Associated Protein 1 (MTA1) in Prostate Cancer Cell Lines (651) MD Hofer, SR Setlur, KD Mertz, MA Rubin - Brigham and Women's Hospital, Boston, MA 82 MLH1 Immunoreactivity in Prostatic Adenocarcinoma (776) XJ Yang, F Lin, T Ruddy, M Han, WJ Catalona - Northwestern University, Chicago, IL; Geisinger Medical Center, Danville, PA; Biocare Medical, Concord, CA 83 Expression Of Claudin 1 And Claudin 7 In Prostatic Adenocarcinoma Whole Mount Sections (719) M Punar, OL Cano, CE Sheehan, TA Jennings, B Mian, JS Ross, T Nazeer - Albany Medical College, Albany, NY 84 Genetic Heterogeneity Of Androgen Sensitive And Androgen Independent Prostate Cancer: An Analysis Of Androgen Receptor CAG Repeat Lengths In Germline, Somatic And Hormone Refractory Prostate Cancer Tissues (748) K Sircar, B Gottlieb, A Aprikian, L Beitel, M Trifiro, C Alvarado - McGill University Health Center, Jewish General Hospital, Montreal, QC, Canada 85 BNIP3 Appeared To Be Increased In Prostate Adenocarcinoma Cells And Tissues (783) H Zeng, N Chen, J Gong, YF Wang, Q Zhou - West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan, China 86 Evaluation Of Serum SELDI-TOF Proteomic Information And Tumor Volume In Prostate Cancer Patients (626) B Furusato, LL Banez, P Prasan, Y Chen, A Ali, JW Moul, DG McLeod, S Srivastava, IA Sesterhenn - Armed Forces Institute of Pathology, Walter Reed Army Medical Center, Washington, DC; Center For Prostate Disease Research, Bethesda, MD 87 SEMA4F Overexpression in Perineural Invasion in Vitro Model of Prostate Cancer (613) H Dai, R Li, M Ittmann, T Wheeler, G Ayala - Baylor College of Medicine, Houston, TX 88 Constitutive Activation of Mammalian Target of Rapamycin (mTOR) and p70S6K in Prostate Cancer (787) G Zotalis, GC Wood, RE Brown - Geisinger Medical Center, Danville, PA 89 Expression of Multiple Survival-Associated Markers in Prostate Cancer with Perineural Invasion (674) R Li, H Dai, T Wheeler, A Frolov, J Spitler, G Ayala - Baylor College of Medicine, Houston, TX 90 High-level Cyclin D1 Is Associated with High Gleason Grade and Predicts Worse Biochemical-free Survival in Prostate Cancer (675) R Li, H Dai, T Wheeler, A Frolov, G Ayala - Baylor College of Medicine, Houston, TX 91 Expression of Proteasome Activator 28³ in Human Prostate Cancer (676) R Li, H Dai, T Wheeler, A Frolov, G Ayala - Baylor College of Medicine, Houston, TX 92 Decreased Expression of Desmin is Associated with Extracapsular Extension and Survival in Prostate Cancer (718) LE Posligua, R Li, TM Wheeler, PT Scardino, A Frolov, GE Ayala - Baylor College of Medicine, Houston, TX 93 Does Quantitative Gene Expression Analysis Of Androgen Recepter In Benign And Neoplastic Prostate Cancer Cells Predict PSA Recurrence? (728) I Rosner, L Ravindranath, B Furusato, Y Chen, I Sesterhenn, DG McLeod, S Srivastava, G Petrovics - WRAMC, AFIP, Washington, DC; CPDR, Bethesda, MD 94 Gene Expression / Biochemical Pathway Signatures Of Benign Prostatic Glands Of Patients With Well And Poorly Differentiated Carcinomas (627) B Furusato, S Shaheduzzaman, V Parachury, G Petrovics, M Nau, M Vahey, DG McLeod, S Srivastava, I Sesterhenn - AFIP, WRAMC, Washington, DC; CPDR, Bethesda, MD 95 MUC-4 Expression in Prostate Cancer (658) M Jorda, C Gomez-Fernandez, I Reis, A PEREZ - University of Miami, Miami, FL 96 Podoplanin Expression In Prostate (738) IA Sesterhenn, CJ Davis, B Furusato, J Miki, H Takahashi, DG McLeod - AFIP, WRAMC, Washington, DC; Jikei University School of Medicine, Jikei University School of Medicine, Tokyo, Japan 97 7NKX3.1 As A New Tissue Marker of Prostatic Adenocarcinoma (582) TZ Ali, JI Epstein, CM Bieberich, AM De Marzo - Univ of Maryland Medical Center, The Johns Hopkins Hospital, Univ Maryland Baltimore County, Baltimore, MD 98 Nucleolar Pattern Telomerase Catalytic Subunit Staining as a Selective Aid in Prostate Biopsy Diagnosis (721) A Radhakrishnan, MW Datta, AL Folpe, A Kuehn, MB Amin - Emory University Hospital, Atlanta, GA 99 Expression Of Ezrin-Radixin-Moesin Proteins, a Membrane Cytoskeletal Crosslinker Complex, In Prostate Adenocarcinoma (606) SI Chiosea, U Chandran, F Monzon, R Dhir - University of Pittsburgh Medical Center, Pittsburgh, PA 100 Fat Tissue Can Be Seen Within Prostatic Parenchyma: A study 139 Whole Mount Radical Prostatectomy Specimens (662) KH Kee, JY Ro, S Shen, AG Ayala - The Methodist Hospital, Houston, TX